Gene · 79188
Papers1,602
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,602
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TMEM-ing the Tide: Gene Therapy Holds Promise for ARVC5. | Circ Res | 2025 | 40208928 | PubTator, text mining | PubMed |
| Editorial: Mechanisms of auditory development, maintenance, damage, and protection. | Front Mol Neurosci | 2025 | 40134466 | PubTator, text mining | PubMed |
| Features of the electrocardiogram in TMEM43 p.S358L arrhythmogenic cardiomyopathy. | Heart Rhythm | 2025 | 40120924 | PubTator, text mining | PubMed |
| GSK3 inhibition ameliorates the abnormal contractility of Newfoundland ACM patient iPSC-cardiomyocytes. | Am J Physiol Cell Physiol | 2025 | 40055648 | PubTator, text mining | PubMed |
| Dynamics of molecular heterogeneity in high-risk luminal breast cancer-From intrinsic to adaptive subtyping. | Cancer Cell | 2025 | 39933898 | PubTator, text mining | PubMed |
| Identification of Biomarkers of Arrhythmogenic Cardiomyopathy (ACM) by Plasma Proteomics. | Medicina (Kaunas) | 2025 | 39859087 | PubTator, text mining | PubMed |
| Analysis of a South African Accredited Cancer Centre - Suspected Correlation between BMI and Biology. | Eur J Breast Health | 2024 | 41952568 | PubTator, text mining | PubMed |
| Modeling of auditory neuropathy spectrum disorders associated with the TEME43 variant reveals impaired gap junction function of iPSC-derived glia-like support cells. | Front Mol Neurosci | 2024 | 39834515 | PubTator, text mining | PubMed |
| Identification of a Potential PGK1 Inhibitor with the Suppression of Breast Cancer Cells Using Virtual Screening and Molecular Docking. | Pharmaceuticals (Basel) | 2024 | 39770478 | PubTator, text mining | PubMed |
| Smartphone scanning is a reliable and accurate alternative to contemporary residual limb measurement techniques. | PLoS One | 2024 | 39621584 | PubTator, text mining | PubMed |
| Electrophysiological Phenotype-Genotype Study of Sustained Monomorphic Ventricular Tachycardia in Inherited, High Arrhythmic Risk, Left Ventricular Cardiomyopathy. | Circ Arrhythm Electrophysiol | 2024 | 39611258 | PubTator, text mining | PubMed |
| Low progesterone receptor levels in high-grade DCIS correlate with HER2 upregulation and the presence of invasive components. | Front Oncol | 2024 | 39011488 | PubTator, text mining | PubMed |
| Unexpected Genetic Twists in Patients with Cardiac Devices. | J Clin Med | 2024 | 38999368 | PubTator, text mining | PubMed |
| A Comprehensive Analysis of Non-Desmosomal Rare Genetic Variants in Arrhythmogenic Cardiomyopathy: Integrating in Padua Cohort Literature-Derived Data. | Int J Mol Sci | 2024 | 38892455 | PubTator, text mining | PubMed |
| Generation of an induced pluripotent stem cell line from a patient with arrhythmogenic right ventricular cardiomyopathy harboring a TMEM43 splice-site variant. | Stem Cell Res | 2024 | 38824800 | PubTator, text mining | PubMed |
| Mutational landscape of HSP family on human breast cancer. | Sci Rep | 2024 | 38816397 | PubTator, text mining | PubMed |
| Molecular subtyping improves breast cancer diagnosis in the Copenhagen Breast Cancer Genomics Study. | JCI Insight | 2024 | 38587073 | PubTator, text mining | PubMed |
| Transmembrane proteins with unknown function (TMEMs) as ion channels: electrophysiological properties, structure, and pathophysiological roles. | Exp Mol Med | 2024 | 38556553 | PubTator, text mining | PubMed |
| Generation of a TMEM43 knockout human induced pluripotent stem cell line (HDZi003-A-1) using CRISPR/Cas9. | Stem Cell Res | 2024 | 38430734 | PubTator, text mining | PubMed |
| A method to estimate the contribution of rare coding variants to complex trait heritability. | Nat Commun | 2024 | 38336875 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79188/papers?page=3